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Nanotechnology is of increasing signiﬁcance. Curation of nanomaterial data into electronic databases
oﬀers opportunities to better understand and predict nanomaterials’ behaviour. This supports inno-
vation in, and regulation of, nanotechnology. It is commonly understood that curated data need to be
suﬃciently complete and of suﬃcient quality to serve their intended purpose. However, assessing data
completeness and quality is non-trivial in general and is arguably especially diﬃcult in the nanoscience
area, given its highly multidisciplinary nature. The current article, part of the Nanomaterial Data Cura-
tion Initiative series, addresses how to assess the completeness and quality of (curated) nanomaterial
data. In order to address this key challenge, a variety of related issues are discussed: the meaning and
importance of data completeness and quality, existing approaches to their assessment and the key
challenges associated with evaluating the completeness and quality of curated nanomaterial data. Con-
siderations which are speciﬁc to the nanoscience area and lessons which can be learned from other
relevant scientiﬁc disciplines are considered. Hence, the scope of this discussion ranges from physico-
chemical characterisation requirements for nanomaterials and interference of nanomaterials with nano-
toxicology assays to broader issues such as minimum information checklists, toxicology data quality
schemes and computational approaches that facilitate evaluation of the completeness and quality of
(curated) data. This discussion is informed by a literature review and a survey of key nanomaterial data
curation stakeholders. Finally, drawing upon this discussion, recommendations are presented concern-
ing the central question: how should the completeness and quality of curated nanomaterial data be
evaluated?
aSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University,
James Parsons Building, Byrom Street, Liverpool, L3 3AF, UK
bSchool of Geography, Earth and Environmental Sciences, University of Birmingham,
Edgbaston, B15 2TT, Birmingham, UK
cNational Institute of Public Health and the Environment (RIVM), Bilthoven,
The Netherlands
dInstitute of Environmental Sciences, Leiden University, Leiden, The Netherlands
eR&R Data Services, 11 Montgomery Avenue, Gaithersburg MD 20877, USA
fPennsylvania Bio Nano Systems LLC, 3805 Old Easton Road, Doylestown, PA 18902,
USA
gInstitute of Applied Computer Sciences (IAI), Karlsruhe Institute of Technology (KIT),
Hermann v. Helmholtz Platz 1, 76344 Eggenstein-Leopoldshafen, Germany
hEuropean Commission, Joint Research Centre, Institute for Health and Consumer
Protection, Via Fermi 2749, 21027 Ispra (VA), Italy
iLaboratory of Environmental Chemistry, University of Gdansk, Wita Stwosza 63,
80-308 Gdansk, Poland
jFaculty of Engineering, Tel Aviv University, Tel Aviv 69978, Israel
kGroningen Biomolecular Sciences and Biotechnology Institute, University of
Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands
lCivil and Environmental Engineering, Carnegie Mellon University, Pittsburgh,
PA 15213-3890, USA
mDepartment of Public Health and Primary Care, K.U.Leuven, Faculty of Medicine,
Unit Environment & Health – Toxicology, Herestraat 49 (O&N 706), Leuven, Belgium
nNational Institute for Occupational Safety and Health, 1095 Willowdale Road,
Morgantown, WV 26505-2888, USA
oCenter for the Environmental Implications of NanoTechnology, Duke University,
PO Box 90287 121 Hudson Hall, Durham, NC 27708, USA.
E-mail: christine.hendren@duke.edu
pDepartment of Environmental and Molecular Toxicology, School of Chemical,
Biological and Environmental Engineering, Oregon State University, 1007 ALS,
Corvallis, OR 97331, USA. E-mail: stacey.harper@oregonstate.edu
†Electronic supplementary information (ESI) available: (1) Detailed information
regarding issues raised in the main text; (2) original survey responses. See DOI:
10.1039/c5nr08944a
This journal is © The Royal Society of Chemistry 2016 Nanoscale, 2016, 8, 9919–9943 | 9919
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
7 
A
pr
il 
20
16
. D
ow
nl
oa
de
d 
on
 2
6/
05
/2
01
6 
10
:0
7:
19
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal  | View Issue
1. Introduction
The technological application of engineered nanomaterials,
known as “nanotechnology”,1–3 is of increasing significance.4–6
Nanomaterials are commonly defined as materials comprising
(a majority of) constituent particles with at least one (external)
dimension in the nanoscale (1–100 nanometres) range.1,7–11
Nanomaterials have been used or considered for use in a wide
variety of areas such as electronics, consumer products, agro-
chemicals and medical applications.2,5,6,12–15 However, con-
cerns have been raised regarding the potential eﬀects of
nanomaterials on the environment and on human
health.4,6,14–16 The study of the properties and behaviour of
nanomaterials is within the domain of “nanoscience”, encom-
passing fields such as “nanoinformatics”, “nanochemistry”,
“nanomedicine” and “nanotoxicology”.
The design of novel nanomaterials with desirable properties
and acceptable safety profiles, as well as the appropriate regu-
lation of both new and existing nanomaterials, relies upon
nanoscience researchers (both experimentalists and compu-
tational modellers), risk assessors, regulators and other rele-
vant stakeholders having access to the necessary data and
metadata.
These data should be suﬃciently complete, including their
associated metadata, and of acceptable quality to render them
fit for their intended purpose e.g. risk assessment. However,
defining what one means by data which are “suﬃciently com-
plete” and of “acceptable quality” is non-trivial in general and
is arguably especially challenging for the nanoscience area.
The current paper is part of a series of articles9,17 that
address various aspects of nanomaterial data curation, arising
from the Nanomaterial Data Curation Initiative (NDCI), where
curation is defined as a “broad term encompassing all aspects
involved with assimilating data into centralized repositories or
sharable formats”.9 A variety of nanomaterial data resources,
holding diﬀerent kinds of data related to nanomaterials in a
variety of formats, currently exist. Many of these were recently
reviewed.9,18,19 The number of nanomaterial data resources is
expected to increase as a result of ongoing research
projects.4,19
An overview of the articles planned for the NDCI series was
presented in Hendren et al.9 At the time of writing, an article
on curation workflows17 was published and articles dedicated
to curator responsibilities, data integration and metadata were
at various stages of development. The current paper addresses
the question of how to evaluate the degree to which curated
nanomaterial data are “suﬃciently complete” and of “accepta-
ble quality”. In order to address this central question, the
current paper addresses a number of key issues: (1) what the
terms data completeness and quality mean; (2) why these
issues are important; (3) the specific requirements for nano-
material data and metadata intended to support the needs of
specific stakeholders; (4) how to most appropriately score the
degree of completeness and quality for a given nanomaterial
data collection. The abstract meaning of data completeness
and quality in a range of relevant disciplines is reviewed and
the importance of these concepts to the area of nanomaterial
data curation is explained. An overview of existing approaches
for characterising the degree of completeness and quality of
(curated) nanomaterial data is presented, with a focus on
those currently employed by curated nanomaterial data
resources. Approaches to evaluating data completeness and
quality in mature disciplines are also reviewed, with a view to
considering how the relatively young discipline of nanoscience
could learn from these disciplines. However, as is also dis-
cussed, there are specific challenges associated with nano-
material data which aﬀect assessment of their completeness
and quality. Drawing upon the discussion of these issues, the
current paper concludes with a set of recommendations aimed
at promoting and, in some cases, establishing best practice
regarding the manner in which the completeness and quality
of curated nanomaterial data should be evaluated.
The snapshot of current practice, discussion of key chal-
lenges and recommendations were informed via a review of
the published literature as well as responses to a survey distrib-
uted amongst a variety of stakeholders associated with a range
of nanomaterial data resources. The survey and responses can
be found in the ESI,† along with an overview of the nano-
material data resources managed by these stakeholders – with
a focus on how they address the issues related to data comple-
teness and quality. The perspectives of individuals involved in
a variety of nanomaterial data resources were captured via this
survey. However, the resources for which respondents agreed
to participate in this survey should not be seen as
comprehensive.9,18,19
For the purposes of the survey, the Nanomaterial Data Cura-
tion Initiative (NDCI) identified 24 data resources that
addressed various nanomaterial data types: from cytotoxicity
test results to consumer product information. Some of the
identified resources were exclusively focussed on nanomaterial
data, whereas others were broader databases holding some
data for nanomaterials. Representatives of the 24 data
resources were contacted by the NDCI and, in total, 12 liai-
sons, corresponding to nine (38%) of the 24 nanomaterial data
resources, responded to the NDCI data completeness and
quality survey. Some of the nine resources incorporated
primary experimental data, whilst others were exclusively
populated via literature curation. Some of these were in-house
resources, whilst others were publicly available via the internet.
The median experience of the survey respondents was 5 years
in the nanomaterial data curation field, 10.5 years in the wider
nanoscience field, and 5.5 years in the broader data curation
field.
The rest of this paper is organised as follows. Section 2
reviews the meaning of data completeness and quality, in
abstract terms, and then explains the importance of these
issues in the context of nanomaterial data curation. Section 3
reviews existing proposals for characterising the completeness
and quality of (curated) nanomaterial data. Section 4 reviews
approaches for evaluating (curated) data completeness and
quality which are employed in mature fields. Section 5 then
discusses the key challenges associated with nanomaterial
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data which need to be taken into account when evaluating
their completeness and quality. Section 6 presents the rec-
ommendations for evaluating curated nanomaterial data com-
pleteness and quality.
2. The meaning and importance of
data completeness and quality
The importance of data completeness and quality is made
clear by explaining what these concepts mean and their impli-
cations for a range of important issues. (Data completeness
and quality are hereafter referred to as Key concept 1 and Key
concept 3, with full descriptions presented in Tables 1 and 3,
respectively.) The precise meanings of these concepts and the
issues with which they are related are defined somewhat diﬀer-
ently in the varied fields which are relevant to nanomaterial
data curation e.g. informatics, toxicology and risk assessment.
Nonetheless, it is possible to provide broad and flexible defi-
nitions which encompass a variety of perspectives.
Broad and flexible definitions of data completeness and
quality are presented in Tables 1 and 3 respectively. These
reflect the diﬀerent and sometimes inconsistent definitions
presented, either implicitly or explicitly, in the literature,
during discussions amongst the co-authors and by respon-
dents to the NDCI data completeness and quality survey. (The
perspectives of the survey respondents are presented in the
ESI.† Literature definitions of data completeness9,20–24 and
quality9,20–23,25,26 are provided in ESI Tables S3 and S5†
respectively.)
Section 6.1.1 proposes that more precise definitions be
adopted by the nanoscience community. These more precise
definitions are generally consistent with the definitions pre-
sented in Tables 1 and 3, but some issues incorporated into
those broad and flexible definitions are deemed out of scope.
However, the definitions provided in Tables 1 and 3 encom-
pass the range of diﬀerent perspectives encountered when pre-
paring this paper. Hence, these definitions serve as a reference
point for the purpose of reviewing existing approaches to
evaluating data completeness and quality in sections 3, 4 and
ESI S2.†
The following discussion expands upon the broad and flex-
ible definitions presented in Tables 1 and 3. The importance
of these concepts for nanomaterial data curation, and the
issues with which they are commonly associated, is explained
with reference to the nanoscience literature.
Data completeness may be considered a measure of the
availability of the necessary, non-redundant data and associ-
ated metadata for a given entity (e.g. a nanomaterial). (Some
scientists consider the availability of “metadata” to be a separ-
ate issue to data completeness.)20,21 The term “metadata” is
broadly defined as “data which describes data”27 or “data
about the data”.28 Defining exactly what is meant by “data” as
opposed to “metadata” is challenging. For example, physico-
chemical characterisation data may be considered metadata
associated with a biological datum obtained from testing a
given nanomaterial in some assay.3 However, precisely deli-
neating “data” and “metadata” lies beyond the scope of the
current article. In this article, data and metadata are collec-
tively referred to as “(meta)data”.
Generally, data completeness assesses the extent to which
experimental details are described and associated experi-
mental results are reported. One means of assessing the
degree of completeness compliance is to employ a minimum
information checklist. (This concept is referred to hereafter as
Key Concept 2 and a broad and flexible definition is presented
in Table 2. Literature definitions28,29 are presented in ESI
Table S4.†) However, one may also draw a distinction between
data which are truly complete and data which are compliant
with a minimum information checklist. The checklist may
simply specify the most important, but not the only important,
(meta)data. For example, in the case of nanomaterial physico-
chemical characterisation, measurement of a large number of
properties might be considered necessary for complete charac-
terisation but not truly essential to achieve all study goals.
These properties might be distinguished from “priority” or
“minimum” properties which are “essential” to determine.3
The degree of data completeness, insofar as this refers to
description of the necessary experimental details and avail-
ability of (raw) data, needs to be evaluated in a range of
diﬀerent nanoscience contexts. Firstly, it impacts the extent to
which data are – and can be verified to be – reproducible.30–33
Reproducibility32–34 is contingent upon the degree to which
the tested nanomaterial is identified and the experimental pro-
tocols, including the precise experimental conditions, are
described.35 Given the context dependence of many properties
Table 1 Key concept 1: data completeness. Broad and ﬂexible
deﬁnition employed for reviewing prior work
The completeness of data and associated metadata may be considered
a measure of the availability of the necessary, non-redundant (meta)
data for a given entity e.g. a nanomaterial or a set of nanomaterials in
the context of nanoscience. However, there is no definitive consensus
regarding exactly how data completeness should be defined in the
nanoscience, or wider scientific, community.9,20–24 Indeed, metadata
availability may be considered an issue distinct from data
completeness.20,21
Data completeness may be considered to include, amongst other kinds
of data and metadata, the extent of nanomaterial characterisation,
both physicochemical and biological, under a specified set of
experimental conditions and time points. It may also encompass the
degree to which experimental details are described, as well as the
availability of raw data, processed data, or derived data from the assays
used for nanomaterial characterisation. Data completeness may be
considered to be highly dependent upon both the questions posed of
the data and the kinds of data, nanomaterials and applications being
considered. Data completeness may be defined in terms of the degree
of compliance with a minimum information checklist (Table 2).
However, when estimating the degree of data completeness, it should
be recognised that this will not necessarily be based upon
consideration of all independent variables which determine, say, a
given result obtained from a particular biological assay. This is
especially the case when data completeness is assessed with respect to
a predefined minimum information checklist (Table 2). Precise
definitions of completeness may evolve in tandem with scientific
understanding.
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which may identify nanomaterials, these two issues are inter-
related. This is because nanomaterial identification, if based
on physicochemical measurements, is not meaningful unless
the corresponding experimental protocols are adequately
described.3,36–40
Providing suﬃcient (meta)data to ensure the nanomaterial
being considered is identified, to the degree required, is also
inherently important to achieve the goals of “uniqueness” and
“equivalency”.41 Establishing “uniqueness” means determin-
ing that nanomaterial A is diﬀerent from B.41 Establishing
“equivalency” means determining that nanomaterial A is –
essentially – the same as B.41 Achieving “uniqueness” allows
so-called “conflicting” results to be resolved.3 Achieving
“equivalency” allows for data integration (e.g. to interrogate
relationships between diﬀerent kinds of data) using data
reported for the same, or functionally equivalent, nano-
material in diﬀerent studies.
Physicochemical characterisation also assists with explain-
ing observed diﬀerences in (biological) eﬀects.3 Indeed, it
facilitates the development of computational models for (bio-
logical) activity, based on the physicochemical properties as
explanatory variables. Modelling of nanomaterial eﬀects may
entail the development of nanomaterial quantitative structure
activity relationships (QSARs) – termed “nano-QSARs”,42 nano-
scale structure–activity relationships (“nanoSARs”)43 and quan-
titative nanostructure–activity relationships (“QNARs”)44 – or
“grouping” and “read-across” predictions for nanomaterial
biological activity.44,45 Reporting of the experimental details
associated with the generation of a given biological or physico-
chemical measurement facilitates assessment of whether data
from diﬀerent sources might be combined for modelling,
given the potential trade-oﬀ between dataset size and
heterogeneity.46,47
Data quality may be considered a measure of the potential
usefulness, clarity, correctness and trustworthiness of data.
Some data quality assessment proposals23,35,48 may talk inter-
changeably about the quality of data, datasets (or “data sets”),
studies and publications. However, subsets of data from a given
source (e.g. a dataset, study report or journal article) may be
considered to be of diﬀerent quality, depending upon exactly
how data quality is defined and assessed.49 For example, the
cytotoxicity data reported in a publication might be considered of
diﬀerent quality compared to the genotoxicity data. As another
example, the data obtained for a single nanomaterial using a
single assay might be considered of higher quality than the
data obtained for a diﬀerent nanomaterial and/or assay.
Whilst the quality of individual data points is an important
issue, data points which – viewed in isolation – may be con-
sidered of insuﬃcient quality to be useful may possibly be
useful when used in combination with other data. For
example, toxicity data which are evaluated as less reliable
might be combined via a “weight-of-evidence” approach.35 As
another example, in the context of statistical analysis, large
sample sizes may partially oﬀset random measurement
errors.50 However, the importance of the reliability of the orig-
inal data which are to be combined cannot be overlooked in
either context.23,50
According to some definitions, data quality may be partly
assessed based upon the relevance of the data for answering a
specific question.27,48 Similarly, data completeness may also
be considered highly context dependent. Here, the specific
context refers to the kinds of data, the kinds of nanomaterials,
the kinds of applications and the kinds of questions that need
to be answered by a particular end user of the data. In other
words, the degree to which the data are complete may be con-
tingent upon “the defined [business] information demand”.27
Table 2 Key concept 2: minimum information checklist. Broad and
ﬂexible deﬁnition employed for reviewing prior work
Minimum information checklists might otherwise be referred to as
minimum information standards, minimum information criteria,
minimum information guidelines or data reporting guidelines etc.28,29
These checklists define a set of data and metadata which “should” be
reported – if available – by experimentalists and/or captured during
data curation. Again, the precise set of data and metadata which
“should” be reported may be considered to be highly dependent upon
both the questions posed of the data and the kinds of data, nano-
materials and applications being considered. There are two possible
interpretations of the purpose of these checklists: (1) they should be
used to support assessment of data completeness (Table 1); (2) data
should be considered unacceptable if they are not 100% compliant
with the checklist.
Table 3 Key concept 3: data quality. Broad and ﬂexible deﬁnition
employed for reviewing prior work
Data quality may be considered a measure of the potential usefulness,
clarity, correctness and trustworthiness of data and datasets. However,
there is no definitive consensus regarding exactly how data quality
should be defined in the nanoscience, or wider scientific,
community.9,20–23,25,26
Data quality may be considered dependent upon the degree to which
the meaning of the data is “clear” and the extent to which the data are
“plausible”.48 In turn, this may be considered to incorporate (aspects
of) data completeness (Table 1). For example, data quality may be con-
sidered23 to be (partly) dependent upon the “reproducibility” of
data31–34 and the extent to which data are reproducible and their repro-
ducibility can be assessed will partly depend upon the degree of data
completeness in terms of the, readily accessible, available metadata
and raw data.30,35 As well as “reproducibility”, data quality may be con-
sidered to incorporate a variety of related issues. These issues include
systematic and random “errors” in the data,32,33 data “precision”
(which may be considered33 related to notions such as
“repeatability”32–35 or “within-laboratory reproducibility”),33 “accuracy”
and “uncertainty”.20,23,25,27,32,33,35,51–55 (As indicated by the cited refer-
ences, diﬀerent scientists may provide somewhat diﬀerent definitions
for these concepts. These concepts may be considered in a qualitative
or quantitative sense.) Data quality may also be considered to be
dependent upon the “relevance” of the data for answering a specific
question, although data “relevance” might be considered an entirely
distinct issue from data quality.23,48 In the context of data curation,
not only the quality of the original experimental data needs to be con-
sidered but also quality considerations associated with curated data.
Quality considerations associated with curation include the probability
of transcription errors56 and possibly57 whether a given dataset, struc-
tured according to some standardised format (e.g. XML based),58 was
compliant with the rules of the applicable standardised format (e.g. as
documented via an XML schema).59 Such compliance, amongst other
possible aspects of data quality, could be determined using validation
software.
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None of the preceding discussion addresses the key ques-
tion of how exactly to evaluate data completeness or quality for
(curated) nanomaterial data. This question will be addressed
in subsequent sections of the current paper.
3. Existing proposals for evaluating
nanomaterial data completeness and
quality
A plethora of proposals has been presented for assessing data
completeness and quality in the nanoscience area. Because it
would not be practical to comprehensively list and discuss all
existing proposals in the current work, the following discus-
sion (sections 3.1 and 3.2) aims to be illustrative of the
diﬀerent proposals which have been developed – with an
emphasis on the most recent and those which are employed
by the maintainers of specific curated nanomaterial data
resources. Examples are taken from the published literature as
well as the responses to the survey which informed the current
article. A summary of the evaluation schemes, if any, employed
by each of the data resources represented by the respondents
to the survey is provided in the ESI.†
3.1. An overview of nanomaterial data completeness
proposals
Considerable attention has been paid to identifying the
minimum set of physicochemical parameters for which it is
anticipated that nanomaterials with similar values for
these parameters would exhibit similar eﬀects in biological
(e.g. toxicological) tests or clinical studies.3 Here, “physicochemical
parameters” refers to the characteristics/properties relevant for
the description of a nanomaterial such as chemical compo-
sition, shape, size and size distribution statistics. A number of
lists exist, including the well-known MINChar Initiative Para-
meters List, proposed in 2008.60 Earlier eﬀorts to provide
minimum characterisation criteria for nanomaterials included
the work carried out by the prototype Nanoparticle Infor-
mation Library (NIL).61–63 The prototype NIL was developed in
2004 to illustrate how nanomaterial data could be organised
and gave examples of what physicochemical parameters, along
with corresponding information regarding synthesis and
characterisation methodology, might be included for nano-
material characterisation (see the ESI† for further details). In
2012, Stefaniak et al. identified and carefully analysed 28 lists
(published between 2004 and 2011) which proposed “pro-
perties of interest” (for risk assessment), from which 18 lists
of “minimum” – or, in their terms, “priority” – properties were
discerned.3 These authors summarised the properties found
on these lists and the corresponding frequency of occurrence
across all lists. Other lists39,64–69 of important physicochemical
parameters have been published subsequent to the analysis of
Stefaniak et al.3
Arguably, within nanoscience, less attention70 has been
paid to the question of which additional experimental details
(e.g. the cell density,71 number of particles per cell,72 cell line
used, passage number used or exposure medium constitu-
ents73,74 in cell-based in vitro assays) need to be recorded. It is
important to note that many of the physicochemical character-
istics which define the identity of a nanomaterial are highly
dependent upon experimental conditions such as the pH and
biological macromolecules found in the suspension
medium.36,39,40 Nonetheless, some lists which specify key
experimental details that should be reported (in addition to
key physicochemical parameters) do exist.3,60,64,66,75,76 Indeed,
it should be noted that some lists focused on the minimum
physicochemical parameters which should be reported also
suggest certain experimental conditions such as “particle con-
centration”3 and “media”60 should be reported. (Here, the
potential ambiguity as to what is considered a physicochemical
parameter for a nanomaterial sample and what is considered
an experimental condition should be noted: “particle concen-
tration”3 and “pH”77 may be considered either as physico-
chemical properties or important experimental conditions.)36
Other proposals, such as the caNanoLab data availability stan-
dard,78 go further and stipulate that other (meta)data, such as
characterisation with respect to specific biological endpoints,
should be made available.
Key international standards bodies, the Organisation for
Economic Co-operation and Development (OECD) and the
International Standards Organisation (ISO), have also made
recommendations regarding physicochemical parameters and
other experimental variables which should be reported for
various kinds of experimental studies of nanomaterials.79–85
Notable reports include the “Guidance Manual for the Testing
of Manufactured Nanomaterials: OECD Sponsorship Pro-
gramme”80 which stipulates physicochemical parameters and
biological endpoints which needed to be assessed, as part of
the OECD’s “Safety Testing of a Representative Set of Manufac-
tured Nanomaterials” project, and a guidance document on
sample preparation and dosimetry,81 which highlights specific
experimental conditions, associated with stepwise sample
preparation for various kinds of studies, that should be
reported.
Many of the proposals cited above are not associated with a
specific curated nanomaterial data resource, although some
which were intended as recommendations for experimentalists
(e.g. the MINChar Initiative Parameters List)60 have been used
as the basis for curated data scoring schemes.78 Examples of
proposals which are specifically used as the basis of a scoring
scheme, partly or wholly based upon data completeness, for
curated nanomaterial data include those employed by the
Nanomaterial Registry,39,86,87 caNanoLab78 as well as the
MOD-ENP-TOX and ModNanoTox projects (see ESI†).
Some proposals draw a distinction between broader com-
pleteness criteria (see Table 1) and what may be considered
“minimum information” criteria (see Table 2). For example,
within the MOD-ENP-TOX project (see ESI†) a set of minimum
physicochemical parameters were required to be reported
within a publication in order for it to be curated: composition,
shape, crystallinity and primary size. Additional physico-
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chemical parameters (such as surface area) were deemed
important for the data to be considered complete. This is in
keeping with many proposals reviewed by Stefaniak et al.,3
which drew a distinction between “properties of interest” and
“minimum” (or “priority”) properties, as well as publications
proposing increasing characterisation requirements within a
tiered approach to nanosafety assessment.67,68
Some proposals have also stressed the context dependence
of completeness definitions. For example, the ModNanoTox
project proposed (see ESI†) that certain physicochemical para-
meters and experimental metadata were only relevant for
certain kinds of nanomaterials: crystal phase was considered
crucial for TiO2 nanoparticles but less important for CeO2
nanoparticles, in keeping with an independent review of the
literature emphasising the importance of crystal phase data for
TiO2 nanomaterials specifically.
68 Recent publications have
also stressed the importance of characterisation requirements
depending upon the type of nanomaterials studied and other-
wise being relevant for the specific study.68,88,89
Indeed, in contrast to the proposals discussed above which
define specific (meta)data requirements, the developers of the
Center for the Environmental Implications of NanoTechnology
(CEINT) NanoInformatics Knowledge Commons (CEINT NIKC)
data resource90–92 have proposed that data completeness be
calculated on a use-case-specific basis i.e. with respect to the
(meta)data which a given database query aims to retrieve. For
example, a researcher interested in the die oﬀ rate of fish due
to nanomaterial exposure would need mortality data at mul-
tiple time points, whereas a researcher interested in mortality
after, say, one week would only need data at a single time
point.
3.2. An overview of nanomaterial data quality assessment
proposals
Various schemes for scoring/categorising nanomaterial data
(in part) according to their quality have been proposed in
recent years. Because data completeness (see Table 1) and
quality (see Table 3) may be considered highly interrelated, a
number of these schemes are strongly based upon consider-
ation of (meta)data availability. One of the simplest schemes,
presented by Hristozov et al.,93 assessed the reliability of tox-
icity data in nanomaterial databases based purely upon the
availability of basic provenance metadata: data were considered
“unusable”, or “unreliable”, where a result from a study is not
accompanied by a “properly cited reference”. Significantly
more sophisticated schemes exist which take into account the
availability of a variety of additional (meta)data such as the
availability of certain physicochemical data and experimental
details concerning biological assay protocols. One such sophis-
ticated scheme is the iteratively developed DaNa “Literature
Criteria Checklist”75,76 used to assess the quality of a given
published study concerning a given nanomaterial for the
purpose of preventing low quality scientific findings from
being integrated within the DaNa knowledge base.94–96
Indeed, some existing nanomaterial quality proposals go
beyond merely considering data completeness, but are also
concerned with whether the experimental protocols were
carried out appropriately. For example, Lubinski et al.47 pro-
posed an extension of the Klimisch framework48 for evaluating
the reliability of nanotoxicology, or nano-physicochemical,
data which was considered, in part, to depend upon compli-
ance with Good Laboratory Practice (GLP)97 and standardised
test protocols. Other assessment schemes, such as the scheme
employed by the DaNa75,76,94–96 project (see ESI†), take
account of whether biological results were aﬀected by assay
interference.98–107 Indeed, application of the DaNa “Literature
Criteria Checklist”75,76 entails making a range of judgements
regarding the quality of the nanomaterial data which go
beyond mere consideration of data completeness (see ESI†).
Likewise, Simkó et al. proposed a range of criteria for evaluat-
ing in vitro studies, including clearly specified criteria for the
statistical “quality of study”.108
Some, but not all, proposals for quality assessment of nano-
material data have sought to assign a categorical or numeric
score to express the quality of the nanomaterial data. One such
scheme, which assigns a qualitative score, was proposed by
Lubinski et al.47 Likewise, the “Data Readiness Levels” scheme
proposed by the Nanotechnology Knowledge Infrastructure
(NKI) Signature Initiative51 assigns any kind of data – i.e. not
necessarily generated for nanomaterials – to one of seven,
ranked categories denoting their “quality and maturity”. In
contrast, the following schemes assign numeric quality scores
and were specifically designed to evaluate nanomaterial data
curated into a specific data resource. The Nanomaterial Regis-
try,109,110 assigns normalised, numeric “compliance” scores to
each nanomaterial record in the database based upon its
associated measurements, corresponding to the physico-
chemical characteristics specified in the “minimal information
about nanomaterials (MIAN)”, which are designed to capture
the “quality and quantity” of the physicochemical characteris-
ation performed for that nanomaterial.39,86,87 The
MOD-ENP-TOX and ModNanoTox curated nanomaterial data
resources also developed quality scoring schemes which assign
numeric scores (see ESI†).
One notion of data quality (see Table 3) might be based on
validation of dataset files, according to their data content or
compliance with format specifications, using specialist soft-
ware tools. (This is further discussed in section 4, with
examples from mature fields.) In the nanoscience area, the
validation tools111 developed within the MODERN E.U. FP7
project,112 used to validate ISA-TAB-Nano datasets based on
their compliance with the ISA-TAB-Nano specification,113–115
were, to the best of the authors’ knowledge, the only such
tools available at the time of writing which were specifically
developed for validating curated nanomaterial datasets.
4. Lessons which can be learned
from mature ﬁelds
In order to improve the means via which the completeness
and quality of (curated) nanomaterial data are currently evalu-
Feature article Nanoscale
9924 | Nanoscale, 2016, 8, 9919–9943 This journal is © The Royal Society of Chemistry 2016
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
7 
A
pr
il 
20
16
. D
ow
nl
oa
de
d 
on
 2
6/
05
/2
01
6 
10
:0
7:
19
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
ated, it is worth considering the lessons which may be learned
from “mature” fields.
A variety of diﬀerent minimum information checklists or
reporting guidelines (see Table 2) have been proposed in
diﬀerent areas of the life sciences. These are increasingly
being used by publishers to assess the suitability of submitted
publications.116–118 The seminal Minimum Information About
a Microarray Experiment (MIAME) reporting guidelines were
proposed over a decade ago to describe the minimum infor-
mation required for microarray data to be readily interpreted
and for results obtained from analysis of these data to be inde-
pendently verified,116,119 which may be achieved if the results
are reproducible. In under a decade, this standard was widely
accepted and most scientific journals adopted these guidelines
as a requirement for publication of research in this area, with
authors being obliged to deposit the corresponding MIAME-
compliant microarray data in recognised public reposi-
tories.116 A variety of similar guidelines116 were subsequently
developed for other life science technologies (e.g. proteo-
mics)120 or studies (e.g. toxicology121 and molecular bioactivity
studies).122 The BioSharing project and online resource,123–126
originally founded as the MIBBI Portal in 2007,28 serves to
summarise proposed “reporting guideline” standards and
promote their development and acceptance. Clearly, the
BioSharing online resource might be used to link to the
various minimum information checklists that have been
(implicitly) developed within the nanoscience domain (see
section 3.1), thereby raising awareness of them and facilitating
their comparison and further development. It is also possible
that some of the recommendations made regarding experi-
mental (meta)data in the (non-nanoscience specific) reporting
guidelines linked to via the BioSharing website may also be
applicable to (specific sub-domains of) the nanoscience area.
The Standard Reference Data Program of the U.S. National
Institute of Standards and Technology (NIST)127 has supported
the evaluation of data in many areas of science and techno-
logy. Typically, data are not only curated but also evaluated
from three perspectives: documentation of the identification
and control of the independent variables governing a measure-
ment; the consistency of measurement results with the laws of
nature; and through comparison with similar measurements.
Over the years it has become clear that, as new phenomena are
identified and measured, it takes years – if not decades – to
truly identify and understand how to control a measurement.
Consequently, initial experiments produce data that primarily
provide guidance for future experiments rather than be recog-
nised as definitive properties. Feedback from the evaluation
eﬀorts to the experimental community is critical for improving
the quality of data.
Chirico et al.53 recently described how NIST data resources
and computational tools can be and are being used to improve
the quality of thermophysical and thermochemical data sub-
mitted for publication within the context of a collaborative
eﬀort between NIST and five key journals.
Because uncertainty may be considered a key aspect
(Table 3), or even the key aspect,25,52 of data quality evaluation,
the approaches to characterising uncertainty proposed by
ISO,25,52 NIST32 and SCENIHR23 merit consideration.
The concept of data quality has received considerable atten-
tion within the toxicology and risk assessment communities
and a number of proposals for assessing the quality of data,
studies or publications have been published.23,48,128–132 A
number of these were reviewed in Ågerstrand et al.133 and Przy-
bylak et al.49 Arguably the most well-known is the framework
proposed by Klimisch et al.48 for categorising the reliability
(see ESI Table S5† literature definition 3.4) of toxicology data,
or a toxicology study test report or publication. The Klimisch
categories are widely employed within regulatory
toxicology.24,49,132,134
Since the original work of Klimisch et al.48 lacked detailed
criteria for assigning their proposed reliability categories, the
ToxRTool program131,135 was proposed as a means of improv-
ing the transparency and consistency with which these cat-
egories were assigned. The program assigns a reliability
category based upon the score obtained after answering a set
of “yes/no” questions. However, it is interesting to note that
neither GLP nor test guideline compliance is explicitly con-
sidered by the ToxRTool when assessing reliability (although
these issues are considered when evaluating “relevance”) –
even though these were deemed key indicators of reliable data
in the original work of Klimisch et al.48 Recently, an extension
to the ToxRTool program was developed by Yang and co-
workers.136 Their approach took the following issues into
account: (1) an assessor might feel that a given ToxRTool cri-
terion was only partially met, rather than it being possible to
simply answer “yes/no” for that question; (2) an assessor
might be unsure of the most appropriate answer to a given
question. Hence, their approach, based on fuzzy arithmetic,
allows toxicity data to be assigned to multiple reliability cat-
egories with diﬀerent degrees of satisfaction.
Consideration of these diﬀerent approaches to evaluating
data quality raises some important questions which arguably
need to be taken into account when designing a scheme for
assessing the quality of nanosafety data or, where applicable,
nanoscience data in general.
1. To what extent should quality be assessed on the basis of
considering data completeness as opposed to making judge-
ments regarding the data such as the “soundness and appro-
priateness of the methodology used”23 or, equivalently,
whether or not a method was “acceptable”?48
2. More specifically, should data be considered most
reliable48 when they were generated according to Good Labora-
tory Practice (GLP),97 or some other “audited scheme”23 and
according to standardised test protocols,133 such as those pre-
sented in OECD Test Guidelines or by ISO? The appropriate-
ness of adherence to standardised test protocols is especially
relevant for testing of nanomaterials (see section 5.11). It may
also be argued that, even for conventional chemicals, data
which were not generated according to standardised test proto-
cols and/or GLP are not necessarily less reliable.48,132,137
3. To what extent should a data quality assessment scheme
be prescriptive as opposed to allowing for flexibility based
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upon expert judgement? Whilst a scheme which is more pre-
scriptive oﬀers the advantage of promoting transparency and
consistency23,131 in the assigned quality scores (or categories),
flexibility based upon allowing for expert judgement may still
be necessary.23
4. Should the outcome of the quality assessment be
expressed numerically? Beronius et al.132 have argued that this
risks implying an undue level of scientific certainty in the final
quality assessment. However, using a qualitative scheme based
on certain criteria being met in order for data to be assigned
to a particular category would fail to assign partial credit to
data meeting a subset of those criteria. Furthermore, as
illustrated by the ToxRTool approach,131,135 a numeric score
might be mapped onto a qualitative category for ease of
interpretation.
5. How can the community best characterise uncertainty to
provide a clearer understanding of data quality?
The preceding discussion concerns proposals which might
be applied by a human expert for the purposes of assessing
data completeness and quality in various domains. In prin-
ciple, where these schemes are suﬃciently prescriptive, rather
than relying on subjective expert judgement they could be
applied programmatically i.e. via parsing a structured elec-
tronic dataset or database using specialist software.
Indeed, various validation software programs have been
developed to validate electronic datasets, based on standar-
dised file formats, according to a range of criteria. For
example, validation programs have been developed to validate
diﬀerent kinds of biological (meta)data reported in XML-
based58,59,138 or ISA-TAB139,140 formats and, more specifically,
raw sequence and sequence alignment data141–144 reported in
FastQ142–144 or Binary Alignment/Map (BAM) format.145 Vali-
dation software146,147 was also developed for crystallographic
data reported in the crystallographic information file (CIF)
format.148
As well as checking format compliance, some of these vali-
dation programs may also be used to enforce compliance with
(implicit) minimum information checklists.138,149 For example,
The Cancer Genome Atlas (TCGA)150 validation software
checks certain fields to ensure they are not “null” (unknown)
or missing, as well as carrying out various other data quality
checks for errors and inconsistencies.138 Software used to vali-
date sequence data may carry out data quality assessment via
calculating a variety of metrics, including those which are
indicative of diﬀerent kinds of possible errors/biases/artefacts
generated during measurement/analysis or possible contami-
nation of the analysed samples.142–144
All of these software programs are potentially relevant to
automatically validating nanomaterial characterisation and/or
biological data. The ISA-TAB format151–153 was recently
extended via the development of ISA-TAB-Nano113–115 to better
capture nanomaterial (meta)data, so the ISA-Tools139,140 soft-
ware might be extended to validate ISA-TAB-Nano datasets. (As
is discussed in section 3.2, some software for validating
ISA-TAB-Nano files already exists.)111,115 Validation software for
CIF files is arguably of particular relevance to building quanti-
tative structure–activity relationships (QSARs), or quantitative
structure–property relationships (QSPRs), for nanomaterials.
Crystallographic data has been used to calculate descriptors
for nano-QSAR (or nano-QSPR) models of inorganic oxide
nanoparticle activities (or properties) in various recent
studies.42,154,155
5. Key challenges
Important challenges are associated with nanomaterial data
which need to be taken into account when evaluating their
completeness and quality. To some extent, a number of these
issues are taken into account in a subset of the existing propo-
sals for evaluating nanomaterial data (see section 3). Other
challenges relate to limitations of (some) of these existing
evaluation proposals. The key challenges are summarised in
Table 4 and explained in the remainder of section 5.
5.1. Uncertainty regarding the most biologically significant
variables
A key challenge associated with defining minimum infor-
mation criteria for nanomaterials is that the current
understanding of the independent variables, such as nano-
material physicochemical properties and other experimental
variables, which contribute most significantly to the variabi-
lity in the outputs of biological assays is arguably
insuﬃcient.3,41,68–70,89,105,156 Understanding which of the
physicochemical properties are most correlated to biological
eﬀects is hampered by the dependence of many of these pro-
perties on experimental conditions (section 5.2), time (section
5.3), dosimetry uncertainty (section 5.4), possible redundancy
in physicochemical data (section 5.5), the potential for arte-
facts in biological studies related to the presence of nano-
materials (section 5.9) and possible confounding factors
(section 5.10).
Table 4 The key challenges which impact completeness and quality
evaluations of (curated) nanomaterial data
Challenge
no. Brief description
5.1 Uncertainty regarding the most biologically significant
variables
5.2 Dependence of many physicochemical properties on
experimental conditions
5.3 Potential time dependence of physicochemical
properties
5.4 Problems expressing dosimetry in biological assays
5.5 Possible redundancy in physicochemical data
5.6 Batch-to-batch variability of nanomaterials
5.7 Context dependency of (meta)data requirements
5.8 Lack of clarity in some existing checklists
5.9 Artefacts in biological studies related to nanomaterials
5.10 Misinterpretations in biological studies
5.11 Uncertainty regarding standardised test guidelines
5.12 Reduced relevance of some standard assays
5.13 Problems with analysis of environmental samples
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5.2. Dependence of many physicochemical properties on
experimental conditions
Many, but not necessarily all, physicochemical parameters
may change significantly depending upon the dispersion (sus-
pension) medium and any additives (e.g. dispersant aids)37 i.e.
many physicochemical characterisation data obtained under
pristine conditions (e.g. dispersed in water) may diﬀer greatly
from those determined for the nanomaterial dispersed in the
medium, plus additives, used for biological testing.36–40,157
This variability makes it diﬃcult to find correlations between
the physicochemical properties and the outcome of biological
assays. No straightforward relationship can be expected to
exist when these properties are measured under pristine con-
ditions, or conditions which otherwise diﬀer from biologically
relevant conditions, even if a simple correlation exists when
the physicochemical properties are measured under biologi-
cally relevant conditions. For example, a recent study found
the positive zeta potential values measured in physiological
saline (pH 5.6) exhibited good linear correlation with acute
lung inflammogenicity, but not the negative values measured
in more basic (pH 7.4) media.157 Other experimental con-
ditions which may significantly aﬀect physicochemical pro-
perties include sample processing details such as sonication
steps.37
As well as making it harder to discern which physico-
chemical parameters are most important to measure and
document, this challenge has the following implications for
data completeness. Firstly, a careful description of the various
factors which could aﬀect physicochemical properties is
required36,38,40,81 in order to establish “uniqueness” and
“equivalency”41 based upon physicochemical characterisation.
Secondly, measurement of many physicochemical character-
istics under biologically relevant conditions, as is considered
best practice,38 should assist with explaining biological results
or developing structure–activity relationships.
5.3. Potential time dependence of physicochemical
properties
Many nanomaterial characteristics may change over time,
depending upon their environment and processing protocols,
such as their state of agglomeration,40,81 their “corona”158–160
of adsorbed (biological) molecules40,161 and even primary par-
ticle characteristics such as chemical composition (e.g. via
dynamic speciation)162,163 or morphology.37 Some of these
changes may be reversible,159,164 whilst other processes may
give rise to irreversible transformations or “aging”165
(“ageing”).166 These time dependent changes in physico-
chemical properties can give rise to changes in their biological
eﬀects.166
The first implication for data completeness is that temporal
metadata,166 along with corresponding processing (e.g. soni-
cation)37 and storage history166 details, are important to
capture. Secondly, because “ageing” may have transformed the
physicochemical characteristics responsible for biological
activity, data for biological studies of nanomaterials might not
be considered complete if key physicochemical characteristics
were not measured at time points corresponding to biological
testing.166
5.4. Problems expressing dosimetry in biological assays
The most appropriate dose metric to use in biological studies
of nanomaterials is unclear and may depend upon the kind of
nanomaterial being considered.167 Nonetheless, it is generally
accepted77,81,167,168 that mass based concentrations and doses
are less appropriate and that dose metrics based on the total
surface area or number of particles should be considered: the
use of mass based concentration units may give misleading
indications as to the rank order of toxicity for diﬀerent
nanomaterials.77
Thus, the use of an inappropriate dose (or concentration)
metric may be considered to adversely aﬀect the clarity, hence
the quality (see Table 3), of nanomaterial biological data. Since
additional physicochemical data are required for conversion of
the mass based concentration (or dose) units (e.g. surface area
measurements or density measurements, depending upon the
approach employed),36,77,81,168 this issue also has implications
for the minimum information criteria which might be pro-
posed for nanomaterial data. N.B. Diﬀerent approaches for
estimating surface area based dose units, based upon diﬀerent
physicochemical measurements, have distinct advantages and
disadvantages: geometric estimates of surface area may be
based upon simplistic assumptions regarding particle geome-
try and fail to take account of porosity, whilst surface area
measurements under dry conditions may not reflect the acces-
sible surface area under biological conditions.36,168
An additional problem is that the nominal, administered
concentration (or dose) may not correspond to the concen-
tration (or dose) delivered to the site of biological
action.101,168–170 Hence, additional data completeness con-
siderations for aquatic toxicity tests include measurements of
exposure levels over the course of the experiment and data
quality concerns arise regarding whether the experimental
methods employed to quantify nanomaterials in complex
media are appropriate (see section 5.13).101,169
5.5. Possible redundancy in physicochemical data
As discussed in section 5.4, diﬀerent kinds of physico-
chemical data may be required to estimate surface area
based dose units, depending upon the approach employed
i.e. this is one source of potential redundancy in physico-
chemical characterisation requirements. However, as is also
discussed in section 5.4, even ignoring other rationales for
obtaining the same physicochemical data, the diﬀerent
strengths and weaknesses of alternative surface area based
dosimetry approaches mean these data cannot be said to be
completely interchangeable. The interrelatedness between
nanomaterial physicochemical properties44,68,154 also means
that, in principle, extensive lists of “essential” properties3
may call for excessive characterisation that is both a burden
for experimentalists and curators. However, the degree of
interrelatedness between physicochemical properties may not
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mean that some properties are entirely interchangeable and,
furthermore, the relationships between diﬀerent properties –
especially if measured under diﬀerent conditions – are argu-
ably hard to discern.68 Indeed, investigating which properties
correlate might be hampered by synthesis challenges5 which
may be associated with producing systematically varied nano-
material libraries.171
Given the lack of complete interchangeability and problems
associated with determining correlations in physicochemical
properties, reducing the necessary physicochemical character-
isation data based on potential redundancy remains a chal-
lenge. Furthermore, a challenge which arises as a consequence
of these correlations is that it may be diﬃcult to interpret the
eﬀect of changing a given property upon biological activity
(hence, the importance of measuring that property) without
this being confounded by variation in other physicochemical
parameters.
5.6. Batch-to-batch variability of nanomaterials
The issue of batch-to-batch variability, i.e. variability in the
properties of nominally identical nanomaterials obtained via
repetitions of nominally the same synthesis, is a key challenge
which is particularly significant for industrially produced
nanomaterials.5,38,172 The implications for data completeness
are arguably that the batch identity of a given nanomaterial (as
denoted via its “batch identifier”,38,173 “lot number”38,173or
“manufacturer lot identifier”)174 should be documented, to
establish nanomaterial “equivalency”,41 even for nano-
materials which are nominally the same e.g. which have the
same trade name. However, since not all nanomaterial syn-
thesis procedures may exhibit the same degree of batch-to-
batch variability,5,38,172 the importance of these metadata may
depend upon the kind of synthesis procedure. Indeed, the
kind of synthesis route may be considered important metadata
to curate174 for this reason and because it may implicitly
convey (biologically relevant) information regarding chemical
composition.175
5.7. Context dependency of (meta)data requirements
Data and metadata requirements may depend upon the experi-
mental scenario and intended use of the data i.e. the specific
context. Not all (meta)data are relevant for all experimental
scenarios. For example, not all physicochemical parameters
are applicable to all kinds of nanomaterials and those physico-
chemical parameters which contribute most significantly to
nanomaterial eﬀects may vary according to the kind of nano-
material, their intended application and the specific eﬀect of
interest.3,68,69,83,88 Likewise, not all of the key experimental
variables which (most) aﬀect the outcome of biological testing
will necessarily be common to all kinds of biological assays.105
For example, whether cytochalasin-B is employed during a
micronucleus assay, which may be used to evaluate the geno-
toxicity of nanomaterials,6,176 can significantly aﬀect the
results.176,177 However, this experimental variable is not rele-
vant for other genotoxicity tests.6,176 Moreover, in practice,
diﬀerent stakeholders will have diﬀerent objectives i.e. the pro-
perties and experimental metadata which are important may
vary between disciplines and user communities, or even within
the same disciplines and communities the information
requirements may vary according to the specific questions
posed of the data.41
Hence, enforcing a single set of “minimum information”
criteria could lead to some existing data being unnecessarily
deprecated due to a lack of completeness even though the
existing (meta)data are suﬃcient for specific purposes.89 For
example, consider toxicological assessment of a commercially
available nanomaterial with limited batch-to-batch varia-
bility,5,38,172 assessed during diﬀerent studies at essentially the
same point in its life-cycle or which is not significantly
aﬀected by “aging”.165 For such a nanomaterial, its trade name
(“X”) might be considered a suﬃciently unique identifier i.e.
one can suppose that essentially the same material is being
referred to in diﬀerent studies of “X” or that the samples being
assessed do not cause significantly diﬀerent biological eﬀects
for the endpoint(s) of interest. If these data were simply being
used to determine whether material “X” could cause a given
set of eﬀects (as determined in diﬀerent studies), enforcing a
requirement for adherence to a “minimum information check-
list” in terms of physicochemical characterisation3 might be
considered unnecessarily stringent i.e. in this context, detailed
physicochemical characterisation might not be required to
establish “equivalency”.41 Conversely, if a nano-QSAR modeller
wished to generalise from these data (e.g. to build a relation-
ship between physicochemical characteristics and a given
adverse eﬀect), then batch-specific physicochemical character-
isation might be considered much more important.
In light of the context dependence discussed here and the
evolving state of nanoscience (e.g. challenge 5.1), those utilis-
ing stringent “minimum information” schemes should antici-
pate that their criteria are not necessarily applicable in all
contexts and are likely to be superseded as the field develops,
instruments improve, and current hypotheses are exhausted.
However, the underlying informational value of current and
past data may nevertheless remain intact.
5.8. Lack of clarity in some existing checklists
Many existing proposals regarding important physicochemical
data specify characteristics which are very broadly defined,
rather than a specific set of measurements,3 making it unclear
to researchers as to which measurements should be made. For
example, many lists propose that the “agglomeration” or
“aggregation” state be determined.3 However, a variety of
diﬀerent measurements (such as number of primary particles
per aggregate or agglomerate, as might be quantified via the
“average agglomeration number”,178 or assessment of particle
size distributions under diﬀerent conditions) might be con-
sidered to assess this.36,179
A related issue is that two protocols which are nominally
measuring the same parameter (such as “average size”), may
actually be providing diﬀerent kinds of information that are
not directly comparable.3,36,38,180 Diﬀerent measurement
techniques, such as transmission electron microscopy (TEM)
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and dynamic light scattering (DLS), employ diﬀerent prin-
ciples and assumptions to estimate “size” and may be
measuring diﬀerent aspects of “size” (e.g. “height above a flat
substrate” or “hydrodynamic diameter”).3,180,181 Some tech-
niques (e.g. TEM) may be used to estimate the “size” of
agglomerates, aggregates or the primary particles, depending
upon how the raw data are analysed,37,182 and diﬀerent
kinds of “average size” may be obtained using the same
technique.36,180,181
The implications for data completeness are that (1) rec-
ommendations for specific kinds of physicochemical data, or
clear guidance regarding acceptable alternatives, should be
provided and (2) corresponding metadata regarding the
measurement technique, the characterisation protocol and a
precise description of the kind of statistical estimate produced
(e.g. arithmetic mean of the number distribution vs. volume
distribution)36 are important to capture.
5.9. Artefacts in biological studies related to nanomaterials
A growing body of literature has raised concerns regarding
various artefacts which may aﬀect the reliability of biological
assessment of nanomaterials.70,98,99,101–107,183–186 These arte-
facts mean that the measurements obtained may not entirely
correspond to the biological phenomena which the studies are
trying to detect. For example, various kinds of nanomaterial
“interference” with commonly used in vitro (cell-based) toxicity
assays have been noted which may lead to overestimation or
underestimation of toxicity.70,98,99,102–107,183–186 In in vivo
aquatic toxicity studies, nanomaterials adhering to the surface
of organisms may inhibit movement – leading to overestima-
tion of mortality.101,187
An immediate implication for evaluating the quality of
(curated) nanomaterial data is the need to evaluate the possi-
bility for artefacts (e.g. interference). This is complicated by
the fact that assay interference may be dependent upon the
specific combination of assay, nanomaterial and tested con-
centration.98,106,185,186 Indeed, the possible dependency of
assay interference on specific physicochemical character-
istics106,185 may be another factor to take into account when
evaluating completeness and quality.
Various recommendations have been made in the experi-
mental literature for detecting and, in some cases, correcting
for possible assay interference.104–106,184,185 In spite of this,
analysis by Ong et al.,185 using a sample size of 200 papers for
each year, suggested that around 95% (90%) of investigations
using colorimetric or fluorescent-based assays published in
2010 (2012) failed to experimentally assess the potential for
nanomaterial interference or, at least, failed to explicitly state
that such potential interferences had been ruled out
experimentally.
5.10. Misinterpretations in biological studies
As well as artefacts which lead to erroneous estimations of tox-
icity, a variety of additional factors may lead to erroneous
interpretation of the cause of the toxicity observed when
testing nanomaterials.104 For example, a failure to experi-
mentally determine the presence of diﬀerent kinds of impuri-
ties (e.g. endotoxin contamination, solvent contamination,
metals) may lead to the observed toxicity being wrongly attrib-
uted to the nominal nanomaterial.104
The implications for data completeness are that
thorough characterisation of the nanomaterial, including
with respect to these key impurities, needs to be carried
out when studying the biological eﬀects of nanomaterials
in order to meet the following objectives: (1) unless the
nanomaterial identity is otherwise clear (see section 5.7), to
associate a specific nanomaterial identity with the observed
biological activity; (2) if desired, to ensure that any mechan-
istic interpretation of the biological eﬀect is correct. Lack of
clarity in the meaning of the data, such as failure to
correctly identify which specific nanomaterial was tested in
an assay, can also be considered to aﬀect data quality (see
Table 3).
5.11. Uncertainty regarding standardised test guidelines
An initial review188 of the applicability of the OECD test guide-
lines to nanomaterials – developed as standardised test proto-
cols for conventional, small molecule chemicals101,188 –
concluded that many (but not all) of these were applicable to
nanomaterials in principle, if coupled with additional gui-
dance documents regarding nanospecific issues.81,188 A related
question is the requirement for OECD test guidelines for para-
meters which are specifically important for nano-
materials.68,189 However, these issues were still not fully
resolved as of the time of writing.68,79,169,179,189–191 Also, at the
time of writing, some standardised protocols for nanomaterial
assessment with respect to a variety of endpoints were under
development by ISO.82,192 Nonetheless, some recent articles in
the nanotoxicology literature have strongly advocated the use
of OECD test guidelines, or other standardised protocols, to
evaluate nanomaterials.103,193,194
Clearly, if the use of established standardised protocols
cannot be assured to address all of the concerns raised
regarding the quality of nanomaterial data (e.g. the artefacts
discussed in section 5.9), this has implications as to whether
adherence to existing standardised protocols should be con-
sidered an indicator of high quality data, as supposed by
some existing data quality evaluation schemes discussed in
sections 3 and 4,47,48 compared to a novel protocol which
may have been specifically designed to address these con-
cerns. Indeed, it is, in principle, possible that the use of
some existing standardised tests might miss novel endpoints
or be based upon assumptions regarding the mode of action
that are not applicable to some nanomaterials. For example,
the use of “omics” methods in nanotoxicology is advocated
due their ability to capture novel modes of action.195
However, the extent, if any, to which nanomaterials can
cause novel harm, act via genuinely novel modes of action –
or even exhibit novelty in the underlying45 mechanisms of
action and/or structure activity relationships – has recently
been debated.14,89,167,196–199
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5.12. Reduced relevance of some standard assays
Another potential problem with some toxicity tests when
applied to nanomaterials, as compared to testing of small
molecules, is that they might be of reduced relevance for
assessment of possible human health eﬀects. For example, the
Ames genotoxicity test and cytotoxicity tests, based on bacterial
cell cultures, might be inappropriate for nanomaterials as bac-
terial sensitivity to nanomaterials may be significantly reduced
compared to human cells,176,200 due to reduced uptake as a
result of the cell wall and lack of endocytosis for bacterial
cells.176 However, it should be noted that Holden et al.201 have
suggested that bacterial studies may still be relevant to asses-
sing potential nanomaterial impacts on human health, at least
in terms of indirect eﬀects following environmental release.
Reduced relevance for human health eﬀects assessment is
sometimes considered to be a data quality issue (see ESI
Table S5† literature definition 3.4).48
5.13. Problems with analysis of environmental samples
The analysis of engineered nanomaterials, along with their
derivatives, in environmental samples provides important
information for risk assessment.202 The engineered nano-
materials first need to be detected, followed by quantification
of their concentration and determination of their physico-
chemical properties.202 In particular, quantification of their
concentration provides a direct means of validating the predic-
tions of fate and transport models.203 However, obtaining
reliable data on engineered nanomaterials in environmental
samples remains challenging.202,203 In part, this reflects the
need to make measurements at or below the detection limits
for many analytical techniques. For example, many analytical
techniques (e.g. dynamic light scattering) have detection
limits101,203–206 which are too high to detect concentrations as
low as those expected for engineered nanomaterials in environ-
mental samples.101,203,205 Recently, single particle inductively
coupled plasma mass spectrometry (SP-ICP-MS) has been
advocated as a possible solution which would allow detection
of realistic environmental concentrations and, in combination
with additional information or assumptions, simultaneous
measurement of particle size distributions.202,203,205 However,
SP-ICP-MS is not without its limitations,202,203 including com-
position dependent size detection limits.205 (Indeed, detection
of small particles is noted to be a problem with many analyti-
cal techniques due to their detection limits and/or low sensi-
tivity for smaller particles.)206,207 In addition to these
challenges, it has been argued that the most serious remaining
problem with analysis of engineered nanomaterials in environ-
mental samples is discriminating engineered from naturally
occurring nanomaterials.203
The key challenges highlighted in this section emphasise
the diﬃculties associated with generating suﬃciently complete
and high quality nanomaterial data. Consideration of these
challenges is critical when evaluating the completeness and
quality of (curated) nanomaterial data.
6. Recommendations for promoting
and improving upon established best
practice
The following recommendations are designed to promote estab-
lished best practice or improve the manner in which the com-
pleteness and quality of curated nanomaterial data are
evaluated. Many of these recommendations are also applicable
to evaluating the completeness and quality of nanomaterial
data reported in, say, the published literature prior to curation.
They were informed by the preceding discussions regarding the
meaning and importance of data completeness and quality
(section 2), existing proposals for evaluating the completeness
and quality of (curated) nanomaterial data (section 3), lessons
which can be learned from mature fields (section 4) and the key
challenges associated with nanomaterial data (section 5). These
recommendations were developed by the authors of the current
publication and were informed by the responses to the Nano-
material Data Curation Initiative (NDCI) survey on data comple-
teness and quality. (Full details of the recommendations made
by specific survey respondents may be found in the ESI.†)
However, they should not be considered to provide a definitive
road-map for progress in this area which is endorsed by all
authors and survey respondents. Rather, they summarise
options for promoting best practice or improving the evaluation
of the completeness and quality of curated nanomaterial data.
These recommendations are divided into five categories:
terminology recommendations (section 6.1), specific (meta)
data requirements (section 6.2), computational tool focused
recommendations (section 6.3), strategic recommendations
(section 6.4), and recommendations regarding the role specific
organisations and scientific communities could play in advan-
cing the manner in which the completeness and quality of
curated nanomaterial data are evaluated (section 6.5).
To allow the reader to get a quick overview, the recommen-
dations are merely summarised in the main text of the article.
An in-depth discussion of these recommendations, including
caveats, is provided in section S4 of the ESI.†
6.1. Terminology recommendations
It is proposed that the following definitions of terms (Table 5)
should be adopted across the nanoscience community. The
Table 5 Recommendations regarding terminology concerning
(curated) data completeness and quality in the nanoscience area
Recommendation
no. Brief description Comment
6.1.1 Specific definitions of
completeness and
quality are
recommended to the
nanoscience
community.
These definitions are
not restricted for use
within the nanoscience
domain. Formal
agreement on terms
should proceed via ISO
or some other
standardisation body.
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particular context in which these terms are explained is nano-
material data curation. However, the definitions and many of
the accompanying notes are relevant to the wider nanoscience,
or broader scientific, community. These definitions build
upon the broad and flexible definitions of (curated) data com-
pleteness (Table 1) and quality (Table 3) presented in section 2.
The new definitions are generally consistent with the defi-
nitions presented in section 2. However, some issues incorpor-
ated into those broad and flexible definitions are deemed out
of scope. For example, it is proposed that the relevance of the
data for a particular purpose should be considered related to
data completeness rather than quality.
The broad and flexible definitions (section 2) were appropri-
ate for reviewing prior work as they ensured that diﬀerent per-
spectives were not deemed out of scope. However, for the sake
of greater clarity, the following, specific definitions are rec-
ommended to the community. This greater clarity will aid con-
sideration of the practical recommendations presented in the
remainder of this article.
6.1.1. Specific definitions of completeness and quality are
recommended to the nanoscience community. The terms data
completeness and quality should be considered to be related
but should not be used interchangeably. Guidance notes
which further clarify the following definitions are presented in
the detailed discussion of these terminology recommen-
dations in ESI S4.†
Data completeness. This is a measure of the extent to which
the data and metadata which serve to address a specific need
are, in principle, available.
Data quality. This is a measure of the degree to which a
single datum or finding is clear and the extent to which it, and
its associated metadata, can be considered correct.
These abstract definitions are further clarified by Fig. 1,
which illustrates the kinds of (meta)data requirements for data
to be assessed as suﬃciently complete and of acceptable
quality. A more detailed discussion of specific (meta)data
requirements is provided in section 6.2.
6.2. Specific (meta)data requirements
6.2.1. Specific (meta)data highlighted by the NDCI survey.
The Nanomaterial Data Curation Initiative (NDCI) survey on
data completeness and quality asked respondents to suggest
the diﬀerent kinds of (meta)data required in order for nano-
material data to be considered suﬃciently complete and of
suﬃcient quality.
They were further asked to consider whether these (meta)
data were only important in specific contexts and to identify
those (meta)data they felt were most important to capture. The
aim here was to capture recommendations even if they went
beyond the (meta)data considered when curating the nano-
material data resource for which they were acting as a liaison.
(See the ESI† for further details.)
Some survey respondents emphasised that their responses
were not intended to be a comprehensive summary of all
(meta)data and considerations which would need to be taken
into account in order to assess the completeness and quality
of curated nanomaterial data. Rather, their responses to these
questions highlighted issues (e.g. nanomaterial ageing) which
they considered to be given insuﬃcient attention. Some
respondents kindly provided detailed lists of (meta)data and
comments regarding additional considerations required for
completeness and quality assessment. Some of these
responses also gave some consideration to the relative impor-
tance and context/use-case dependence of certain kinds of
(meta)data requirements.
The recommendations regarding physicochemical data
which should be provided were generally in keeping with the
kinds of physicochemical data recommended as being impor-
tant in the lists analysed by Stefaniak et al.3 As well as physico-
chemical data, many kinds of metadata were also highlighted
as being important for data to be determined to be suﬃciently
complete and/or of suﬃcient quality. Metadata recommen-
dations were concerned with various issues, including experi-
mental conditions, protocols and techniques, as well as data
provenance, nanomaterial synthesis and experimental error.
Based on the survey responses and the literature review
which informed the current article, a definitive list of all
necessary (meta)data cannot be made. Neither can a definitive
set of lists presenting all (meta)data requirements for diﬀerent
scenarios be made. Nonetheless, some key recommendations
may be made.
6.2.2. Key recommendations regarding specific (meta)data.
Table 6 presents key recommendations concerning specific
kinds of (meta)data which are important to capture in various
curated nanomaterial data collections. ESI S4† explains these
recommendations in detail.
It should be noted that these recommendations are not a
comprehensive list of all kinds of (meta)data which need to be
captured in curated nanomaterial data collections. Rather,
they are designed to emphasise key issues which are not
always captured in existing minimum information checklists
(section 3.1) or quality assessment schemes (section 3.2) for
(curated) nanomaterial data. Additional (meta)data require-
ments might be determined via consulting existing proposals
(see sections 3.1 and 3.2). Indeed, the need to consult existing
recommendations is a key strategic recommendation (rec-
ommendation 6.4.1).
However, the possible dependence of (meta)data require-
ments upon the kinds of data and intended use of those data
must be remembered (see section 5.7). This consideration is
applicable, in principle, to the existing proposals (see sections
3.1 and 3.2) as well as the recommendations in Table 6. To
some extent, the context dependence of the recommendations
is indicated in Table 6. The discussion of these recommen-
dations in ESI S4† considers this context dependence in
greater depth.
6.3. Computational recommendations
Table 7 presents recommendations regarding how compu-
tational tools might be developed to support evaluation of the
completeness and quality of curated nanomaterial data. Some
of these recommendations concern existing nanoinformatics
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Fig. 1 The quality and completeness of (curated) nanomaterial data are viewed as overlapping, yet distinct, concepts. This ﬁgure illustrates various
contexts, meaning the experimental scenario and intended use of the data, and the kinds of (meta)data which may be required to assess those data
as being suﬃciently complete and of acceptable quality. N.B. (1) PCCs is an abbreviation for physicochemical characteristics. (2) The concept of data
completeness applies to a set of data and their associated metadata. Hence, the number of data points of a speciﬁc kind (e.g. number of nano-
materials screened in a cytotoxicity assay) may be a completeness criterion in speciﬁc contexts if a given number of data points are required to
achieve a speciﬁc aim. (3) In contrast, the concept of data quality applies to a single datum (i.e. a single data point) or a single “ﬁnding”, taking into
account its associated metadata. A “ﬁnding” might be a conclusion derived from analysis of a set of raw or processed data and the “metadata”
associated with that ﬁnding might include these data. (4) The dependence of both completeness and quality upon metadata is not entirely for the
same reasons. For example, metadata (e.g. related to the nanomaterial identity and experimental conditions) are required to determine the relevance
of the data for answering a speciﬁc question. The relevance of data for answering a speciﬁc question aﬀects the completeness of the data, since
only relevant data should be counted when evaluating completeness, but not the quality of a datum or ﬁnding. In addition, metadata are required to
make the meaning of the datum or ﬁnding clear, reducing uncertainty in a qualitative sense and facilitating reproducibility, and to assess the level of
trust, reproducibility, repeatability, uncertainty and error. All of these issues aﬀect the quality of a datum or ﬁnding. However, the quality of a datum
or ﬁnding does not directly aﬀect the completeness of the data. (5) The context determines the (meta)data required for completeness. Whilst quality
is not dependent upon the intended use of the data, the speciﬁc (meta)data required for quality assessment may be dependent upon the experi-
mental scenario. For example, speciﬁc kinds of (meta)data will be required in speciﬁc in vitro studies to assess assay interference and, hence, assess
the error in a given datum. (6) The examples in this ﬁgure are by no means exhaustive or, necessarily, minimum requirements. The example contexts
and their requirements are not necessarily mutually exclusive. For example, a nano-QSAR might be developed via integrating data across multiple in
vitro mechanistic studies. (7) Where examples are provided in this ﬁgure of speciﬁc metadata which might be required for data completeness in
diﬀerent contexts, it should be recalled that the availability of these metadata could also aﬀect the quality of individual data points or ﬁndings.
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Table 6 Key recommendations regarding speciﬁc (meta)data which are important for nanomaterials
Recommendation
no. Brief description When is this important?
6.2.2.1 For many physicochemical properties, in-house
determination, including under biologically relevant
exposure conditions, is recommended.
In principle, whenever reporting physicochemical data from
biological studies. However, the caveats documented in the
detailed discussion of this recommendation, in the ESI,
should be noted.
6.2.2.2 Temporal metadata are particularly important to capture. In principle, when reporting data from any experimental
study
6.2.2.3 (Meta)data allowing for assessment of possible artefacts are
required.
In principle, when reporting data from any biological study
6.2.2.4 (Meta)data related to experimental errors and uncertainty
are required.
In principle, when reporting data from any experimental
study
6.2.2.5 Data identifying (biologically significant) impurities are
important.
In principle, when reporting data from any experimental
study
6.2.2.6 Various manufacturer supplied IDs should be recorded. In principle, when trying to integrate data from diﬀerent
experimental studies
6.2.2.7 Suﬃcient metadata should be provided to precisely identify
any measured data.
When reporting data from any experimental study
6.2.2.8 Provenance metadata are essential. For all curation eﬀorts
6.2.2.9 Data regarding the surface composition and structure/
morphology are important.
In principle, when reporting data from any experimental
study. N.B. The surface composition and structure/
morphology may arise due to a ligand shell/layer.
Table 7 Computational recommendations to support evaluation of the completeness and quality of curated nanomaterial data
Recommendation
no. Brief description Comment
6.3.1 Computational tools for assessment of completeness and
quality should be developed.
Careful consideration of the extent to which completeness
and quality assessment could be automated using these tools
is required and may be contingent upon progress towards
recommendation 6.3.2. Recommendation 6.3.3 is also
pertinent here.
6.3.2 Standard templates for data exchange should be
developed based upon the ISA-TAB-Nano specification.
Some early work towards this objective has already been
carried out. The required templates are likely to be scenario
specific.
6.3.3 Nanomaterial data resources providing completeness and
quality scores should allow end-users to customise these
based upon their own requirements.
The scoring systems should include the ability to customise
and select the criteria upon which the degree of data
completeness (in terms of fitness for purpose), or quality, is
defined and provide the decision process and justification
involved in this. The potential need to customise data
completeness scoring primarily stems from the dependency of
completeness on the use-case. The potential need to
customise data quality scoring primarily stems from the lack
of universal standards as to quality determination.
Table 8 Recommended strategies to improve the manner in which the completeness and quality of nanomaterial data are evaluated in future work
Recommendation
no. Brief description Comment
6.4.1 Proposals for minimum information and data quality requirements could be
informed via expert consensus, building upon existing proposals.
Recommendations 6.4.1, 6.4.2 and 6.4.3
are not mutually exclusive.
6.4.2 Proposals for minimum information and data quality requirements could be
informed via targeted experimental studies.
Recommendations 6.4.1, 6.4.2 and 6.4.3
are not mutually exclusive.
6.4.3 Proposals for minimum information requirements could be informed via
data mining.
Recommendations 6.4.1, 6.4.2 and 6.4.3
are not mutually exclusive.
6.4.4 To reduce redundancy in physicochemical characterisation requirements,
further modelling (or experimental) eﬀorts targeting the interrelatedness of
diﬀerent physicochemical characteristics are required.
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resources, whilst other computational tools may need to be
developed de novo.
6.4. Strategic recommendations
The proposals in Table 8 should be considered in order to
develop scientific strategies for improving the manner in
which the completeness and quality of nanomaterial data are
evaluated in future work.
6.5. Institutional and community level recommendations
Table 9 summarises recommendations regarding initiatives
which could be undertaken by various organisations, in collab-
oration with the wider nanoscience community, to improve the
manner in which the completeness and quality of nano-
material data are evaluated.
7. Conclusions
The curation of nanomaterial data into electronic resources is
crucial to realise the potential of nanotechnology to deliver
benefits to society whilst having acceptable impacts upon
human health and the environment. In order for these data to
be fit for their intended purposes, they need to be suﬃciently
complete and of acceptable quality. Hence, appropriate evalu-
ation of the quality and completeness of curated nanomaterial
data is essential even if, in practice, analysis and conclusions
may need to be drawn from imperfect data: such an evaluation
can inform awareness of the limitations of any work based
upon the available data. Any such evaluation needs to take
account of the issues related to the completeness and quality
of the underlying experimental data as well as additional
issues related to their curation such as transcription errors.
However, carrying out this evaluation in practice is non-trivial.
There are diﬀerent perspectives as to exactly what these terms
mean as well as diﬀerent proposals as to how exactly the
degree of completeness and quality of (curated) nanomaterial
data should be evaluated in practice. After reviewing various
existing proposals in light of broad and flexible definitions of
these concepts, which accommodate the varying range of per-
spectives, more precise definitions are recommended to the
nanoscience community. None of the existing proposals
reviewed herein is perfect. A variety of challenges exist which
impede appropriate evaluation of the completeness and
quality of nanomaterial data. These challenges include the
need to appropriately take account of the dependency of nano-
material properties on their processing and storage history (i.e.
time dependency), artefacts associated with biological testing
of nanomaterials and incomplete understanding of which
physicochemical properties and other experimental variables
most significantly impact the eﬀects of nanomaterials. In
addition, the data requirements are likely to be dependent
upon the precise experimental scenario (e.g. type of nano-
materials) and stakeholder requirements (e.g. regulatory
decisions regarding a single nanomaterial vs. computational
modelling). Some lessons might be learned from work in
mature fields, such as the possibility of developing appropriate
software tools to facilitate the eﬃcient and transparent evalu-
ation of (curated) experimental data. In the nanoscience
domain, automated evaluation of data completeness and
quality might best be supported via further development of
nascent nanoinformatics resources. Common data collection
templates based upon the ISA-TAB-Nano data exchange specifi-
cation are envisaged. These will likely need to be adapted to
the specific data requirements of diﬀerent experimental scen-
arios and stakeholder objectives. The development of these
resources will require community driven consensus regarding
nanomaterial data requirements, which will best be supported
by appropriate organisations and initiatives with an inter-
national reach. This article is one outcome of just such an
initiative, the Nanomaterial Data Curation Initiative (NDCI), as
reflected in the wide range of contributors and stakeholders
who provided a variety of perspectives which informed the
current work and resulted in a variety of recommendations to
promote best practice and improve evaluation of the complete-
ness and quality of (curated) nanomaterial data. An overview of
the perspectives of these diﬀerent stakeholders is presented in
the ESI† of the current article.
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